HHS Preparing to Hand Off Control of Pricing, Coverage of COVID Shots

August 19, 2022 by Dan McCue
HHS Preparing to Hand Off Control of Pricing, Coverage of COVID Shots
Health and Human Services Secretary Xavier Becerra speaks during a news conference June 28, 2022, in Washington. (AP Photo/Patrick Semansky, File)

WASHINGTON — The Biden administration will reportedly convene a meeting on Aug. 30 with state health officials and executives from the drug and pharmacy industries to lay the groundwork for transferring greater control of pricing and coverage for COVID-19 shots and treatments to the private sector.

The scheduling of the session was first reported by The Wall Street Journal.

The meeting, informally called a planning session, is reportedly being held under the auspices of the U.S. Department of Health and Human Services. 

The Well News reached out to the department for comment, but had received no response by Friday afternoon.

Like the Trump administration before it, the Biden administration has always planned to end the federal government footing the bill for interventions to prevent and treat COVID-19 cases and transfer it to the health care industry. 

The move would be a concrete sign the world-roiling pandemic has been largely turned back on its heel.

The question though, as the rate of infection ebbed and flowed and new variants emerged, has always been when the transfer of responsibilities to the drug companies and pharmacies and other COVID-19 stakeholders would occur.

With the rate of infection coming sharply down since the spring, and the Centers for Disease Control and Prevention relaxing its guidance on prevention, the time to make change seems to have come.

Based on CDC data, the number of new COVID-19 infections in metropolitan counties across the U.S. fell by 12% last week, while in rural counties the number of infections dropped by 5%.

Further, as of Aug. 10, the current seven-day moving average of daily new cases (103,614) decreased 13.8% compared with the previous seven-day moving average (120,151).

Among other things, the transfer of responsibility will mean an inevitable rise in the cost to consumers, who so far have merely had to show up at a vaccination center, roll up a sleeve, and be on their way without making a payment.

The good news on that front is that the process for moving the payments for COVID-19 drugs and vaccines to the commercial marketplace is expected to take months, according to The Wall Street Journal, which cited a source speaking on background.

And there are, of course, many questions that still need to be resolved. These include issues of reimbursement, equitable access to vaccines and treatment and how to make the shots and treatments available to the estimated 30 million people who don’t have insurance coverage.

A total of 223,457,170 Americans had been fully vaccinated against COVID-19, or 67.3% of the country’s population, according to CDC data.

Dan can be reached at [email protected] and @DanMcCue

A+
a-
  • COVID treatment
  • drugmakers
  • health
  • Health and Human Services
  • pharmacies
  • vaccines
  • In The News

    Health

    Voting

    Health

    December 8, 2023
    by Dan McCue
    FDA Approves a CRISPR-Based Medicine to Treat Sickle Cell Disease

    WASHINGTON — The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology for... Read More

    WASHINGTON — The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology for the treatment of sickle cell disease. The new treatment, called Casgevy, was manufactured by Vertex Pharmaceuticals, of Boston, Massachusetts, and CRISPR Therapeutics, of Switzerland, using a... Read More

    Chronic Fatigue Syndrome More Common Than Past Studies Suggest, CDC Says

    NEW YORK (AP) — Health officials on Friday released the first nationally representative estimate of how many U.S. adults have... Read More

    NEW YORK (AP) — Health officials on Friday released the first nationally representative estimate of how many U.S. adults have chronic fatigue syndrome: 3.3 million. The Centers for Disease Control and Prevention's number is larger than previous studies have suggested, and is likely boosted by some... Read More

    December 8, 2023
    by Tom Ramstack
    White House Threatens to Penalize Pharma Companies for High Prices

    WASHINGTON — The Biden administration announced a plan Thursday to lower prescription drug costs in a move that takes a... Read More

    WASHINGTON — The Biden administration announced a plan Thursday to lower prescription drug costs in a move that takes a tough stance toward pharmaceutical companies charging high prices. If the Federal Trade Commission determines the prices are unreasonable, the new policy allows the federal government to... Read More

    December 6, 2023
    by Dan McCue
    House Unanimously Passes Bill to Increase Mental Health Resources for Veterans’ Caregivers

    WASHINGTON — The House on Monday unanimously passed the Caregiver Outreach and Program Enhancement Act, which would increase mental health... Read More

    WASHINGTON — The House on Monday unanimously passed the Caregiver Outreach and Program Enhancement Act, which would increase mental health resources available to caregivers of America’s veteran population. Alternately known as the COPE Act, the bipartisan legislation sponsored by Reps. Chrissy Houlahan, D-Pa., and Jen Kiggans,... Read More

    December 6, 2023
    by Dan McCue
    HHS Unveils Next Steps to Enhance Cybersecurity of Health Care Records

    WASHINGTON — The bad guys in cyberspace want your health care records.  Between 2018 and 2022, there was a 93%... Read More

    WASHINGTON — The bad guys in cyberspace want your health care records.  Between 2018 and 2022, there was a 93% increase in large breaches in the health care sector, with a 278% increase in large breaches involving ransomware, according to the Department of Health and Human... Read More

    December 6, 2023
    by Dan McCue
    New Report Sheds Some Light on Rare Post-COVID Shot Syndrome

    NEW HAVEN, Conn. — A study from the Yale School of Medicine sheds some new light on the rare, but... Read More

    NEW HAVEN, Conn. — A study from the Yale School of Medicine sheds some new light on the rare, but chronic and debilitating condition some people report experiencing after getting a COVID-19 vaccination. The paper, which was posted on the preprint server medRxiv and has not... Read More

    News From The Well
    scroll top